Biofidelity has developed molecular biology technologies, Aspyre® and Enspyre®, that enable local and cost-effective genomic analysis for cancer diagnosis and treatment selection. This approach addresses the challenge of limited access to biomarker testing, ensuring more patients receive timely and appropriate targeted therapies.
Funding
$61.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many cancer patients do not receive the biomarker testing required to match them with appropriate targeted therapies. Existing genomic testing methods can be complex, slow, and unreliable, hindering access to precision-driven genomic insights at every stage of the patient journey.
Solution
Biofidelity offers molecular biology technologies, Aspyre® and Enspyre®, designed to simplify and accelerate genomic analysis for cancer diagnosis and treatment selection. Aspyre® enables sensitive and reproducible detection of actionable biomarkers from liquid biopsy samples. Enspyre® is a novel target enrichment technology that enhances next-generation sequencing (NGS) efficiency by selectively removing background DNA, improving sensitivity and reducing costs. Together, these technologies provide an end-to-end solution for early detection, treatment selection, and minimal residual disease monitoring, ensuring more patients receive timely and appropriate targeted therapies.
Target Audience
Biofidelity's primary customers include providers, laboratories, and biopharmaceutical companies seeking to improve access to and efficiency of genomic biomarker testing for cancer patients.
Features
- Aspyre® reagents for consistent and reproducible detection of key biomarkers in liquid biopsy samples
- Enspyre® target enrichment technology to improve NGS signal-to-noise ratio
- Selective enrichment of specified variants prior to sequencing
- Enhanced sensitivity for minimal residual disease (MRD) testing
- Streamlined workflow for simple implementation and analysis
- Solutions for early detection, treatment selection, and disease monitoring